Blackstone bets a billion on PTC Therapeutics; Grant Ave brings in Brian Berkin for healthcare expertise

Blackstone inks deal with PTC Therapeutics.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this